Literature DB >> 4852531

Intra-arterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx.

J M Richard, H Sancho, Y Lepintre, J Rodary, B Pierquin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4852531     DOI： 10.1002/1097-0142(197409)34:3<491::aid-cncr2820340303>3.0.co;2-g

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

Review 1.  Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.

Authors:  Ambika Parmar; Michaelina Macluskey; Niall Mc Goldrick; David I Conway; Anne-Marie Glenny; Janet E Clarkson; Helen V Worthington; Kelvin Kw Chan
Journal:  Cochrane Database Syst Rev       Date:  2021-12-20

2.  Intravenous chemotherapy with syndronization in advanced cancer of oral cavity and oropharynx.

Authors:  M Auersperg; E Soba; O Vraspir-Porenta
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1977-11-18

Review 3.  Interventional Management of Head and Neck Tumors.

Authors:  Mudassar Kamran; Adam N Wallace; Amole Adewumi
Journal:  Semin Intervent Radiol       Date:  2020-05-14       Impact factor: 1.513

4.  Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.

Authors:  Benjamin Lacas; Alexandra Carmel; Cécile Landais; Stuart J Wong; Lisa Licitra; Jeffrey S Tobias; Barbara Burtness; Maria Grazia Ghi; Ezra E W Cohen; Cai Grau; Gregory Wolf; Ricardo Hitt; Renzo Corvò; Volker Budach; Shaleen Kumar; Sarbani Ghosh Laskar; Jean-Jacques Mazeron; Lai-Ping Zhong; Werner Dobrowsky; Pirus Ghadjar; Carlo Fallai; Branko Zakotnik; Atul Sharma; René-Jean Bensadoun; Maria Grazia Ruo Redda; Séverine Racadot; George Fountzilas; David Brizel; Paolo Rovea; Athanassios Argiris; Zoltán Takácsi Nagy; Ju-Whei Lee; Catherine Fortpied; Jonathan Harris; Jean Bourhis; Anne Aupérin; Pierre Blanchard; Jean-Pierre Pignon
Journal:  Radiother Oncol       Date:  2021-01-27       Impact factor: 6.280

5.  An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer.

Authors:  A J Munro
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.